We are live on
!
Find out more
APM
Avidity Partners Management Portfolio holdings
AUM
$936M
1-Year Est. Return
195%
This Fund
S&P 500
This Quarter
Est. Return
+45.78%
1 Year Est. Return
+195%
3 Year Est. Return
+460.87%
5 Year Est. Return
+815.5%
10 Year Est. Return
–
AUM
$159M
AUM Growth
–
Cap. Flow
+$138M
Cap. Flow
% of AUM
86.65%
Top 10 Holdings %
Top 10 Hldgs %
52.06%
Holding
33
New
33
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Baxter International
BAX
|
+$13.7M |
| 2 |
HCA Healthcare
HCA
|
+$8.42M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$8.1M |
| 4 |
AbbVie
ABBV
|
+$7.8M |
| 5 |
Zimmer Biomet
ZBH
|
+$7.75M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 98.13% |
Similar funds
NM
PWAM
CM
LJAC
NI
MCM
TS
TW
Avidity Partners Management's Q4 2019 Portfolio in Review
Q4 2019 is the first quarter with a 13F filing on record for Avidity Partners Management, which disclosed 33 positions worth $159M. Its ten largest holdings account for 52% of the portfolio.
Its largest position is Baxter International: 165,000 shares worth $13.8M.
By sector, the portfolio is most concentrated in Healthcare at 98% of assets.
- Avidity Partners Management's largest Q4 2019 buy was Baxter International: 165,000 shares worth $13.8M.
- Avidity Partners Management's ten largest holdings make up 52% of its $159M portfolio in Q4 2019.
- Avidity Partners Management disclosed 33 positions in Q4 2019, its first 13F filing on record.
Based on Avidity Partners Management's 13F filing for Q4 2019, filed 14 Feb 2020.